Viewing Study NCT01498068


Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2025-12-29 @ 9:20 PM
Study NCT ID: NCT01498068
Status: COMPLETED
Last Update Posted: 2015-01-30
First Post: 2011-12-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C
Sponsor: Janssen-Cilag International NV
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-01
Start Date Type: None
Primary Completion Date: 2012-04
Primary Completion Date Type: ACTUAL
Completion Date: 2013-03
Completion Date Type: ACTUAL
First Submit Date: 2011-12-06
First Submit QC Date: None
Study First Post Date: 2011-12-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-09-11
Results First Submit QC Date: None
Results First Post Date: 2013-12-30
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-01-29
Last Update Post Date: 2015-01-30
Last Update Post Date Type: ESTIMATED